Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

NCT01434576 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor withdrew study for business reasons

Conditions

Ulcerative Colitis

Interventions

BIOLOGICAL: HGS1025
BIOLOGICAL: HGS1025
DRUG: Placebo

Sponsor

Human Genome Sciences Inc.